Effect and safety of tamsulosin, the prostate specific alpha(1)-blocker, in the treatment of BPH (benign prostatic hyperplasia)

被引：2
|
作者：
Kawabe, K
机构：
[1] Department of Urology, Faculty of Medicine, The University of Tokyo, Tokyo
来源：
AKTUELLE UROLOGIE | 1996年 / 27卷
关键词：
BPH; alpha-blocker; alpha(1a)-receptor-subtype; tamsulosin;
D O I：
10.1055/s-2008-1055642
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
Clinical trials of tamsulosin demonstrate that it is an effective treatment modality for the symptoms associated with BPH, and it has practically no effect on blood pressure at a dose of 0.2 mg. This is probably due to its selective affinity for the prostate, which may be due to the strong affinity of tamsulosin for the alpha(1a)-receptor subtype.
引用
收藏
页码：25 / 26
页数：2
相关论文
共 50 条
  • [11] Treatment Patterns in Alpha-Blocker Therapy for Benign Prostatic Hyperplasia
    Schoenfeld, Michael J.
    Shortridge, Emily F.
    Gelwicks, Steven C.
    Cui, Zhanglin
    Wong, David G.
    AMERICAN JOURNAL OF MENS HEALTH, 2014, 8 (03) : 267 - 272
  • [12] Photoselective vaporization of the prostate(PVP) for treatment of huge benign prostatic hyperplasia(BPH)
    Jung, Gyung-woo
    Ok, Yunchul
    JOURNAL OF UROLOGY, 2007, 177 (04): : 613 - 614
  • [13] Photoselective vaporization of the prostate (PVP) for treatment of huge benign prostatic hyperplasia (BPH)
    Gyunawoo, J.
    Yunchul, O.
    EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (02) : 192 - 192
  • [14] Negative signalling for growth and survival in epithelial prostate cells in vivo in benign prostatic hyperplasia (BPH) after tamsulosin
    Carballido, J
    Prieto, A
    Sanz, M
    Vela-Navarrete, R
    Korstanje, C
    de Mon, MA
    JOURNAL OF UROLOGY, 2003, 169 (04): : 480 - 480
  • [15] Evaluation of Safety and Efficacy of Alfuzosin and Tamsulosin in Benign Prostatic Hyperplasia
    Praveen, R.
    Kumar, T. N.
    Sen
    INDIAN JOURNAL OF PHARMACOLOGY, 2013, 45 : S119 - S120
  • [16] Efficacy and safety of tamsulosin in patients with benign prostatic hyperplasia (BPH): Clinical experience in the primary care setting.
    Flannery, MT
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2001, 49 (04) : S85 - S85
  • [17] Prostate artery embolization (PAE) for benign prostatic hyperplasia (BPH)
    Somani, Bhaskar K.
    Hacking, Nigel
    Bryant, Timothy
    Coyne, John
    Flowers, David
    Harris, Mark
    Dyer, Jonathan
    BJU INTERNATIONAL, 2014, 114 (05) : 639 - 640
  • [18] Tamsulosin versus transurethral resection of the prostate: Effect on nocturia as a result of benign prostatic hyperplasia
    Simaioforidis, Vasileios
    Papatsoris, Athanasios G.
    Chrisofos, Michael
    Chrisafis, Manolis
    Koritsiadis, Sotirios
    Deliveliotis, Charalambos
    INTERNATIONAL JOURNAL OF UROLOGY, 2011, 18 (03) : 243 - 248
  • [19] Risk stratification for benign prostatic hyperplasia (BPH) treatment
    Emberton, Mark
    Fitzpatrick, John M.
    Rees, Jon
    BJU INTERNATIONAL, 2011, 107 (06) : 876 - 880
  • [20] Minimally Invasive Treatment in Benign Prostatic Hyperplasia (BPH)
    Sciacqua, L. V.
    Vanzulli, A.
    Di Meo, R.
    Pellegrino, G.
    Lavorato, R.
    Vitale, G.
    Carrafiello, G.
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2023, 22
12345